|
|
Article: Pfizer Prevails in Accupril Patent Suit.
- Article from:
- PR Newswire
- Article date:
- June 30, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pfizer Prevails in Accupril Patent Suit
NEW YORK, June 30 -- Pfizer Inc said today it has prevailed in a patent
infringement suit in which Teva Pharmaceuticals USA Inc. (Teva), was seeking
approval to sell a generic version of Pfizer's blood pressure medicine Accupril
(quinapril hydrochloride).
In a June 29 decision, Judge Dickinson R. Debevoise of the United States
District Court for the District of New Jersey held that Warner-Lambert's
patent on a stable formulation of quinapril (U.S. 4,743,450), was valid,
infringed and enforceable against Teva. The decision affirmed the court's
previous findings of infringement and validity. The court also ...